Abstract:Abstract Background Neuroprotective nutritional interventions involving greater consumption of polyunsaturated fats (Mediterranean diet, fish consumption or DHA supplements) are less effective in APOE4 carriers with dementia compared to non‐carriers. We recently demonstrated greater activation of calcium dependent phospholipase A2 (cPLA2) in APOE4 compared with non‐APOE4 using both postmortem human brains and in brain tissues from APOE4 animal models. Activation of cPLA2 is associated with lower omega‐3 brain levels and lower measures of blood‐brain barrier (BBB) integrity as assessed using 7T DCE MRI to derive contrast transfer values (K trans). Method Here, we present new data on aging (18 months) old APOE mouse models on a low DHA diet, APOE4‐TR mice treated with LPS and APOE knock out mice as a model of lower BBB integrity. All models were treated with the brain penetrant cPLA2 inhibitor ASB14780 at 10 mg/kg IP daily over 8 weeks in the aging model and acutely (7 days) in the younger LPS and APOE KO models. Result cPLA2 inhibition was associated with increased brain omega‐3 levels in both the aging APOE4 model and in the younger APOE4 mice treated acutely with LPS. In the aging APOE4 mouse model, cPLA2 inhibition associated with better performance on novel object recognition, improved synaptic markers, and lower microglial activation. In the APOE KO model, treatment was associated with improved measures of BBB with lower K trans following treatment (Figure). Conclusion The results here demonstrate how neuroinflammation associated with APOE4 depletes brain omega‐3s via activation of cPLA2 and how reducing cPLA2 activity can rescue this phenotype. The development of specific and potent brain penetrant cPLA2 inhibitors promises to enhance the brain effects of omega‐3 enriched diets by limiting the effects of neuroinflammation on the aging APOE4 brain.

Eicosapentaenoic Acid-Enriched Phospholipids Improve Aβ1–40-induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease

A Comparative Study of Eicosapentaenoic Acid Enriched Phosphatidylcholine and Ethyl Ester in Improving Cognitive Deficiency in Alzheimer's Disease Model Rats.

Eicosapentaenoic Acid Enriched Phosphatidylcholine Mitigated Aβ1-42 Induced Neurotoxicity Via Autophagy-Inflammasome Pathway.

DHA-PC and DHA-PS Improved Aβ1–40 Induced Cognitive Deficiency Uncoupled with an Increase in Brain DHA in Rats

EPA Enriched Ethanolamine Plasmalogens Significantly Improve Cognition of Alzheimer’s Disease Mouse Model by Suppressing Β-Amyloid Generation

Comparative Study of Different Polar Groups of EPA‐Enriched Phospholipids on Ameliorating Memory Loss and Cognitive Deficiency in Aged SAMP8 Mice

The Protective Effect of Eicosapentaenoic Acid-Enriched Phospholipids from Sea Cucumber Cucumaria Frondosa on Oxidative Stress in PC12 Cells and SAMP8 Mice

Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ23-35-Induced Alzheimer's Disease Rat Model.

Mechanisms of DHA-enriched Phospholipids in Improving Cognitive Deficits in Aged SAMP8 Mice with High-Fat Diet

Comparative Studies of DHA-enriched Phosphatidylcholine and Recombination of DHA-ethyl Ester with Egg Phosphatidylcholine on Ameliorating Memory and Cognitive Deficiency in SAMP8 Mice.

Enhanced Neuroprotective Effect of DHA and EPA-enriched Phospholipids Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Induced Oxidative Stress in Mice Brain

A Comparative Study of EPA-enriched Ethanolamine Plasmalogen and EPA-enriched Phosphatidylethanolamine on Aβ42 Induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease

EPA-enriched Ethanolamine Plasmalogen and EPA-enriched Phosphatidylethanolamine Enhance BDNF/TrkB/CREB Signaling and Inhibit Neuronal Apoptosis in Vitro and in Vivo.

A comparative study of the effects of phosphatidylserine rich in DHA and EPA on Aβ-induced Alzheimer's disease using cell models

A Comparative Study about the Neuroprotective Effects of DHA-Enriched Phosphatidylserine and EPA-Enriched Phosphatidylserine Against Oxidative Damage in Primary Hippocampal Neurons.

Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice Fed with High-fat Diet

Novel mechanisms to enhance omega‐3 brain metabolism with APOE4

N-3 Polyunsaturated Fatty Acids Attenuate Amyloid-Beta-induced Toxicity in AD Transgenic Caenorhabditis Elegans Via Promotion of Proteasomal Activity and Activation of PPAR-gamma.

A Comparative Study about EPA-PL and EPA-EE on Ameliorating Behavioral Deficits in MPTP-induced Mice with Parkinson’s Disease by Suppressing Oxidative Stress and Apoptosis

A Comparative Study about the Neuroprotective Effects of EPA-Enriched Phosphoethanolamine Plasmalogen and Phosphatidylethanolamine Against Oxidative Damage in Primary Hippocampal Neurons

Eicosapentaenoic Acid in the Form of Phospholipids Exerts Superior Anti-Atherosclerosis Effects to Its Triglyceride Form in ApoE(-/-) Mice